Dr Leonid Nikitenko L.Nikitenko@hull.ac.uk
Lecturer in Biomedical Sciences
Dr Leonid Nikitenko L.Nikitenko@hull.ac.uk
Lecturer in Biomedical Sciences
Professor Simon Hart S.Hart@hull.ac.uk
Professor in Respiratory Medicine
Miss Karolina Jagielka
This is an annual follow up/annual review for the Project 3632727: Development And Publication Of The Booklet For The Pulmonary Fibrosis (disease With A Degree Of Similarity To Coronavirus Disease).
Chronic diseases associated with fibrosis present a challenge for healthcare; two of them are idiopathic pulmonary fibrosis (IPF) and lymphoedema. IPF is a form of lung disease in which scarring occurs (with no known cause) leading to increased breathing difficulties.
More than 3 million people aged 70-75 worldwide suffer from this disease and it is the most common interstitial lung disease in the UK with an incidence of around 7 cases per 100,000 people. Whilst there are antifibrotic drugs such as pirfenidone and nintedanib available, there is no treatment to stop the scarring. Symptoms of IPF include a persistent dry cough, tiredness, weight loss and clubbed fingers. Most of these symptoms are also present in COVID-19 infection. Hence, it is important that clinicians and patients are educated and understand the differences between the two diseases so that a correct treatment plan is devised and so that the patients can give informed consent.
Before 2020, in the Hull University Teaching Hospitals NHS Trust there was no resource for patients in the Respiratory Medicine department other than a 'Home Ventilation Information for Patients' leaflet while other departments have multiple resources. This highlighted the need of educating patients especially as the Yorkshire and Humber region has had rates higher than those in England for under 75 mortality rate from respiratory disease in 2015-2016 (39.7 vs 43.3/100,000). My research group focuses on understanding the role of pathogenesis of chronic diseases and works closely with clinicians in Hull and nationwide. In 2020, together with one of University of Hull interns Miss Karolina Jagielka, Dr Simon Hart and our PhD student Mr Eamon Faulkner, we developed a booklet for IPF awareness in Hull and involved patients, public and clinicians to improve the quality of the booklet. The booklet has been published
https://hull-research.worktribe.com/record.jx?recordid=3666470
and disseminated with support of Pulmonary Fibrosis Trust. This allowed knowledge exchange as it has become an easily accessible resource with key information, which begun to have a positive impact on the community. The requested in this application funding is required for covering the costs of the review and printing of the second edition of this booklet.
Status | Project Complete |
---|---|
Value | £401.00 |
Project Dates | Nov 1, 2022 - Oct 31, 2023 |
Development and application of a multi-scale computational model of sarcoidosis to predict therapeutic approaches for non-self-resolving disease Jun 30, 2017 - Aug 31, 2020
An in silico computational model of sarcoidosis
BREATHE: Breathlessness RElief AT HomE Apr 1, 2019 - Oct 31, 2021
A feasibility study to address this RQ:
Does a paramedic-administered short non-pharmacological complex breathlessness intervention improve breathlessness and reduce conveyance to ED for people with breathlessness crisis compared with usual practice...
Read More about BREATHE: Breathlessness RElief AT HomE.
Sir Jules Thorn PhD Scholarship Programme 2016 Sep 1, 2016 - Aug 31, 2019
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lungs that affects about 15,000 people in the UK. There is no curative treatment and 5-year survival in IPF is worse than many cancers. Despite this, the pathogenesis of IPF...
Read More about Sir Jules Thorn PhD Scholarship Programme 2016.
Characterisation of monocyte CD200R in pulmonary sarcoidosis Mar 1, 2016 - Feb 28, 2018
Differentiating the malignant potential of pancreatic cysts Oct 1, 2017 - Dec 31, 2022
The effective diagnosis of pancreatic cancer is often quite challenging, due to a lack of disease-specific symptoms, resulting in the majority of patients presenting with advanced disease, with an associated dismal prognosis. Earlier detection of pan...
Read More about Differentiating the malignant potential of pancreatic cysts.
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search